Bone metabolism disorder in epileptic children
Iranian Journal of Child Neurology,
Vol. 12 No. 2 (2018),
14 March 2018
Background and Objective: There are frequent anti-epileptic drugs which are used in management of epilepsy. Anti-epileptic drugs may have some complications on bone and vitamin-D metabolism. In this study we aimed to Comparison of Bone metabolism disorder in epileptic children with health child in zahedan
Methods: This case-control study was performed on bone metabolism disorder in epileptic children. Forty epileptic children was enetered to the study based on accessability scheme and 40 participants randomly selected for control group from those who were referred to the centers for rutine check up. Blood samples were collected from all participants to assess serum calcium, phosphorus, PTH, magnesium, vitamin D, calcium urine, serum albumin, creatinine random urine. Statistical analyses were performed using SPSS software.
Results: Of 40 epileptic children 23 (57.5%) and 17 (42.5%) were male and female respectively. The prevalence of low vitamin D was 37.5% for patients compared to 12.5% for controls (chi-square = 6.667 and p= 0.010). Of 80 participants, 15 individuals had abnormal PTH level which is distributed of 2 and 13 for patients and control groups respectively (chi-square = 9.928 and p= 0.002). In the cases of Ca and Mg their levels were similar in both patients and controls. The status of the parameters in the classification of normal and abnormal assessed based on number of medications intake resulted that number of medications intake had not effect on the parameters status.
Conclusion: our study, like previous studies showed that in epileptic children, frequency of hyperparathyroidy and vitamin D deficiency increased.
- Anti_epileptic drugs
- bone metabolism
Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ. 2001;79:344–351
Petty SJ, O'Brien, TJ, Wark JD. Anti-epileptic medication and bone health.International Osteoporosis Foundation and National Osteoporosis Foundation 2006.
Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA .Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures2002. Epilepsia 43(11):1402–1409.
Kruse R. Osteopathies in antiepileptic long-term therapy preliminary report in German 1968 . Monatsschr Kinderheilkd 116 (6):378–381.
Schmid F Osteopathien bei antiepileptischer Dauerbehandlung 1967. Fortschr Med 85:381–382.
Valmadrid C, Voorhees C,Litt B, Schneyer CR .Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy2001. Arch Neurol 58(9):1369–1374.
Gröber U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermato-endocrinology. 2012 Apr 1;4(2):158-66.
Gough H, Goggin T, Bissessar A, et al. A comparative study of the relative influence of different anticonvulsant drugs,UV exposure and diet on vitamin D and calcium metabolism in outpatients with epilepsy. Q J Med 1986;59:569 –577.
Bogliun G, Beghi E, Crespi V, et al. Anticonvulsant drugs and bone metabolism. Acta Neurol Scand 1986;74:284 –288.
Hoikka V, Savolainen K, Esko M, Alhava EM. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Acta Neurol Scand 1981;64:122–131.
Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic drug induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781–786.
Alison M. Pack, MD,1 Martha J. Morrell, MD,1 Robert Marcus, MD,2 Leah Holloway, MS,3 Edith Flaster, MS,1 Silvia Don˜e, BA,1 Alison Randall, BA,1 Cairn Seale, MS,2 and Elizabeth Shane . Bone Mass and Turnover in Women with Epilepsy on Antiepileptic Drug Monotherapy, MD4-Ann Neurol 2005;57:252–257.
S. bone J. Petty , O'Brien TJ, Wark JD. Anti-epileptic medication and health Received: 9 June 2005 , Accepted: 12 June 2006 , Published online: 8 November 2006.
Delucia MC, Mitnick ME, Carpenter TO. Nutritional rickets with normal circulating 25-hydroxyvitamin D: A call for re-examining the role of dietary calcium intake in north American infants. J Clin Endocribol Metab. 2003;88(8):3539-45.
Zhonghua Er Ke Zhi. Effect of carbamazepine and valproate on bone metabolism in children with epilepcy.2005 Oct;43(10):728-32.
Zalman S Agus, Marc K Drezner. Metabolism of vitamin D. UpToDate 2009; version 17.3 (September 5, 2009).
J Forensic Leg Med, Murie J, Messow CM, Fitzpatrick B . Feasibility of screening for and treating vitamin D deficiency in forensic psychiatric inpatients.2012 Nov;19(8):457-64. doi: 10.1016/j.jflm.2012.04.003. Epub 2012 May 4.
Ashrafi MR, Khoshhal F, Rabani A, Salajegheh N, Nasab AM, Shams S, Ashtiani MH, Sotodeh A. Study of Antiepileptic Drugs effects on bone metabolism. Iranian Journal of Pediatrics. 2005;15(4):347-52.
Sina Nettekoven, Alexander Ströhle, Birgit Trunz, Maike Wolters, Susanne Hoffmann, Rüdiger Horn,et al.Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy . Received: 27 September 2007 , Revised: 8 January 2008 , Accepted: 13 January 2008 , Published online: 13 February 2008.
Zarrin Keyhani doost MD, Heshmat Moayyeri MD, Nahideh Khosroshahi MD, Rasool Molatefi MD. The evaluation of 25-hydroxy vitamin D, calcium, phosphate and alkaline phosphatase levels in epileptic children under antiepileptic medication. Tehran University Medical Journal; Vol. 68, No. 10, Jan 2011: 590-594 .
Fong CY, Riney CJ.Vtamin D deficiency among children with epilepcy in south Queensland.J chil Neourol.2014 Mar;29 (3):368-73. Doi: 10.Epub 2013 jan 22.
- Abstract Viewed: 203 times
- PDF Downloaded: 123 times